Annual accounts receivable:
$171.16M-$10.35M(-5.70%)Summary
- As of today (May 29, 2025), CHE annual accounts receivable is $171.16 million, with the most recent change of -$10.35 million (-5.70%) on December 31, 2024.
- During the last 3 years, CHE annual accounts receivable has risen by +$33.95 million (+24.74%).
- CHE annual accounts receivable is now -5.70% below its all-time high of $181.51 million, reached on December 31, 2023.
Performance
CHE Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$285.87M+$114.71M(+67.02%)Summary
- As of today (May 29, 2025), CHE quarterly accounts receivable is $285.87 million, with the most recent change of +$114.71 million (+67.02%) on March 31, 2025.
- Over the past year, CHE quarterly accounts receivable has increased by +$108.54 million (+61.21%).
- CHE quarterly accounts receivable is now at all-time high.
Performance
CHE Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
CHE Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.7% | +61.2% |
| 3 y3 years | +24.7% | +143.7% |
| 5 y5 years | +19.0% | +112.2% |
CHE Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -5.7% | +24.7% | at high | +143.7% |
| 5 y | 5-year | -5.7% | +34.9% | at high | +172.9% |
| alltime | all time | -5.7% | +1092.7% | at high | +2047.8% |
CHE Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $285.87M(+67.0%) |
| Dec 2024 | $171.16M(-5.7%) | $171.16M(-12.9%) |
| Sep 2024 | - | $196.48M(+6.2%) |
| Jun 2024 | - | $184.96M(+4.3%) |
| Mar 2024 | - | $177.33M(-2.3%) |
| Dec 2023 | $181.51M(+30.2%) | $181.51M(+8.0%) |
| Sep 2023 | - | $168.03M(+39.7%) |
| Jun 2023 | - | $120.31M(-21.8%) |
| Mar 2023 | - | $153.82M(+10.3%) |
| Dec 2022 | $139.41M(+1.6%) | $139.41M(+14.6%) |
| Sep 2022 | - | $121.66M(-10.9%) |
| Jun 2022 | - | $136.56M(+16.4%) |
| Mar 2022 | - | $117.32M(-14.5%) |
| Dec 2021 | $137.22M(+8.2%) | $137.22M(+16.1%) |
| Sep 2021 | - | $118.19M(-4.2%) |
| Jun 2021 | - | $123.33M(+17.7%) |
| Mar 2021 | - | $104.75M(-17.4%) |
| Dec 2020 | $126.85M(-11.8%) | $126.85M(+14.4%) |
| Sep 2020 | - | $110.84M(-16.3%) |
| Jun 2020 | - | $132.49M(-1.6%) |
| Mar 2020 | - | $134.69M(-6.3%) |
| Dec 2019 | $143.83M(+20.4%) | $143.83M(+25.6%) |
| Sep 2019 | - | $114.48M(-15.9%) |
| Jun 2019 | - | $136.11M(+13.8%) |
| Mar 2019 | - | $119.58M(+0.1%) |
| Dec 2018 | $119.50M(+5.1%) | $119.50M(+9.6%) |
| Sep 2018 | - | $109.00M(-8.6%) |
| Jun 2018 | - | $119.21M(+7.1%) |
| Mar 2018 | - | $111.33M(-2.0%) |
| Dec 2017 | $113.65M(-13.9%) | $113.65M(+24.2%) |
| Sep 2017 | - | $91.48M(-22.4%) |
| Jun 2017 | - | $117.91M(+7.5%) |
| Mar 2017 | - | $109.73M(-16.9%) |
| Dec 2016 | $132.02M(+24.2%) | $132.02M(+53.5%) |
| Sep 2016 | - | $86.01M(-13.1%) |
| Jun 2016 | - | $98.95M(-30.8%) |
| Mar 2016 | - | $143.04M(+34.6%) |
| Dec 2015 | $106.26M(-14.7%) | $106.26M(-14.1%) |
| Sep 2015 | - | $123.67M(+3.8%) |
| Jun 2015 | - | $119.12M(-18.3%) |
| Mar 2015 | - | $145.76M(+17.0%) |
| Dec 2014 | $124.61M(+35.8%) | $124.61M(-5.8%) |
| Sep 2014 | - | $132.34M(+43.6%) |
| Jun 2014 | - | $92.15M(-20.7%) |
| Mar 2014 | - | $116.15M(+26.6%) |
| Dec 2013 | $91.77M(-1.7%) | $91.77M(+14.5%) |
| Sep 2013 | - | $80.12M(+4.9%) |
| Jun 2013 | - | $76.36M(-40.0%) |
| Mar 2013 | - | $127.22M(+36.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $93.33M(+19.8%) | $93.33M(-7.7%) |
| Sep 2012 | - | $101.15M(+23.6%) |
| Jun 2012 | - | $81.81M(-26.1%) |
| Mar 2012 | - | $110.66M(+42.0%) |
| Dec 2011 | $77.92M(-31.0%) | $77.92M(-30.9%) |
| Sep 2011 | - | $112.72M(-4.7%) |
| Jun 2011 | - | $118.28M(+27.3%) |
| Mar 2011 | - | $92.91M(-17.8%) |
| Dec 2010 | $113.00M(+111.4%) | $113.00M(+6.9%) |
| Sep 2010 | - | $105.69M(+3.9%) |
| Jun 2010 | - | $101.74M(+16.4%) |
| Mar 2010 | - | $87.41M(+63.5%) |
| Dec 2009 | $53.46M(-45.5%) | $53.46M(-49.9%) |
| Sep 2009 | - | $106.67M(+2.4%) |
| Jun 2009 | - | $104.12M(-3.0%) |
| Mar 2009 | - | $107.36M(+9.5%) |
| Dec 2008 | $98.08M(-3.1%) | $98.08M(+11.2%) |
| Sep 2008 | - | $88.21M(-13.0%) |
| Jun 2008 | - | $101.40M(+16.5%) |
| Mar 2008 | - | $87.00M(-14.0%) |
| Dec 2007 | $101.17M(+8.7%) | $101.17M(+23.8%) |
| Sep 2007 | - | $81.72M(-18.2%) |
| Jun 2007 | - | $99.87M(+17.2%) |
| Mar 2007 | - | $85.21M(-8.5%) |
| Dec 2006 | $93.09M(+2.2%) | $93.09M(-10.7%) |
| Sep 2006 | - | $104.24M(+9.9%) |
| Jun 2006 | - | $94.83M(+32.0%) |
| Mar 2006 | - | $71.86M(-21.1%) |
| Dec 2005 | $91.09M(+40.9%) | $91.09M(+7.8%) |
| Sep 2005 | - | $84.47M(-0.6%) |
| Jun 2005 | - | $84.97M(+3.8%) |
| Mar 2005 | - | $81.88M(+26.6%) |
| Dec 2004 | $64.66M(+350.6%) | $64.66M(-9.5%) |
| Sep 2004 | - | $71.48M(+21.1%) |
| Jun 2004 | - | $59.03M(-8.2%) |
| Mar 2004 | - | $64.31M(+348.1%) |
| Dec 2003 | $14.35M(-2.0%) | $14.35M(+7.8%) |
| Sep 2003 | - | $13.31M(-12.4%) |
| Jun 2003 | - | $15.19M(+3.4%) |
| Mar 2003 | - | $14.69M(+0.3%) |
| Dec 2002 | $14.64M(-3.2%) | $14.64M(-0.9%) |
| Sep 2002 | - | $14.77M(-70.9%) |
| Jun 2002 | - | $50.79M(-0.6%) |
| Mar 2002 | - | $51.08M(+237.7%) |
| Dec 2001 | $15.13M(-72.3%) | $15.13M(-70.5%) |
| Sep 2001 | - | $51.29M(+0.8%) |
| Jun 2001 | - | $50.90M(-4.1%) |
| Mar 2001 | - | $53.10M(-2.7%) |
| Dec 2000 | $54.57M(-37.6%) | $54.57M(-37.6%) |
| Dec 1994 | $87.50M | $87.50M |
FAQ
- What is Chemed annual accounts receivable?
- What is the all time high annual accounts receivable for Chemed?
- What is Chemed annual accounts receivable year-on-year change?
- What is Chemed quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Chemed?
- What is Chemed quarterly accounts receivable year-on-year change?
What is Chemed annual accounts receivable?
The current annual accounts receivable of CHE is $171.16M
What is the all time high annual accounts receivable for Chemed?
Chemed all-time high annual accounts receivable is $181.51M
What is Chemed annual accounts receivable year-on-year change?
Over the past year, CHE annual accounts receivable has changed by -$10.35M (-5.70%)
What is Chemed quarterly accounts receivable?
The current quarterly accounts receivable of CHE is $285.87M
What is the all time high quarterly accounts receivable for Chemed?
Chemed all-time high quarterly accounts receivable is $285.87M
What is Chemed quarterly accounts receivable year-on-year change?
Over the past year, CHE quarterly accounts receivable has changed by +$108.54M (+61.21%)